Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaíba-based Mouthwash for Oral Mucositis in Oral Cancer Patients During Radiotherapy
NCT06708702Phase 2Withdrawn
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of copaiba in oral mucositis (OM), sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Planned start Jan 2025; status: withdrawn.
02
Drugs
copaiba
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT06708702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06708702.